89 related articles for article (PubMed ID: 33760670)
1. Role of Interleukin-10 Promoter Polymorphisms in Oral Cancer Susceptibility: A Meta-Analysis.
Liu RY; Li L; Wu T; Zhang ZT
Cancer Invest; 2021 May; 39(5):390-400. PubMed ID: 33760670
[TBL] [Abstract][Full Text] [Related]
2. Common Polymorphisms of
Rezaei F; Doulatparast D; Sadeghi M
J Interferon Cytokine Res; 2020 Jul; 40(7):357-369. PubMed ID: 32598201
[TBL] [Abstract][Full Text] [Related]
3. Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.
Li F; Xu X; Xuan C; Chen WT
Histol Histopathol; 2020 Nov; 35(11):1329-1336. PubMed ID: 33119124
[TBL] [Abstract][Full Text] [Related]
4. A -819 C/T polymorphism in the interleukin-10 promoter is associated with persistent HBV infection, but -1082 A/G and -592A/C polymorphisms are not: a meta-analysis.
Ren H; Zhang TT; Hu WL
Arch Virol; 2015 Mar; 160(3):747-56. PubMed ID: 25583543
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese.
Hsu HJ; Yang YH; Shieh TY; Chen CH; Kao YH; Yang CF; Ko EC
Kaohsiung J Med Sci; 2015 Mar; 31(3):123-9. PubMed ID: 25744234
[TBL] [Abstract][Full Text] [Related]
7. Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk.
You Y; Du X; Fan M; Wu B; Xie C
Int J Clin Exp Med; 2015; 8(8):13187-94. PubMed ID: 26550242
[TBL] [Abstract][Full Text] [Related]
8. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.
Tsai CW; Chang WS; Lin KC; Shih LC; Tsai MH; Hsiao CL; Yang MD; Lin CC; Bau DT
Anticancer Res; 2014 Jul; 34(7):3731-7. PubMed ID: 24982395
[TBL] [Abstract][Full Text] [Related]
9. Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis.
Wang P; An J; Zhu Y; Wan X; Zhang H; Xi S; Li S
Oncotarget; 2017 Sep; 8(37):62382-62399. PubMed ID: 28977953
[TBL] [Abstract][Full Text] [Related]
10.
Liu L; Zheng F
Onco Targets Ther; 2016; 9():6083-6091. PubMed ID: 27785055
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations of IL-10: Identification of novel variations and evaluation of the impact of the SNPs/haplotype in the promoter region with the progression of Oral Squamous Cell Carcinoma in Indian population.
Sharma U; Singhal P; Bandil K; Kumar A; Bose S; Ahuja P; Kohli M; Dewan AK; Tayal J; Banerjee BD; Prasheri A; Mehrotra R; Sharma V; Bharadwaj M
Cytokine; 2018 Mar; 103():99-108. PubMed ID: 28982581
[TBL] [Abstract][Full Text] [Related]
12. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Liu CM; Yeh CJ; Yu CC; Chou MY; Lin CH; Wei LH; Lin CW; Yang SF; Chien MH
Oral Dis; 2012 Apr; 18(3):307-14. PubMed ID: 22151543
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms in the IL-10 gene with susceptibility to esophageal, nasopharyngeal, and oral cancers.
Li YF; Yang PZ; Li HF
Cancer Biomark; 2016 Mar; 16(4):641-51. PubMed ID: 27002767
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis.
Nie W; Fang Z; Li B; Xiu QY
Cytokine; 2012 Dec; 60(3):849-55. PubMed ID: 23017230
[TBL] [Abstract][Full Text] [Related]
16. ASSOCIATION OF PROMOTER REGION POLYMORPHISMS OF INTERLEUKIN-10 GENE WITH SUSCEPTIBILITY TO COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Mirjalili SA; Moghimi M; Aghili K; Jafari M; Abolbaghaei SM; Neamatzadeh H; Mazaheri M; Zare-Shehneh M
Arq Gastroenterol; 2018; 55(3):306-313. PubMed ID: 30540096
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10-1082A/G polymorphism and diabetic nephropathy: a meta-analysis.
Peng X; Xu J; Wang P; Zhou J; Guo H
Med Sci Monit; 2015 Mar; 21():890-4. PubMed ID: 25806430
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of interleukin-10 (-A592C) among oral cancer with squamous cell carcinoma.
Singh PK; Ahmad MK; Kumar V; Gupta R; Kohli M; Jain A; Mahdi AA; Bogra J; Chandra G
Arch Oral Biol; 2017 May; 77():18-22. PubMed ID: 28157558
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in interleukin-10 gene and risk of oral cancer.
Yao JG; Gao LB; Liu YG; Li J; Pang GF
Clin Chim Acta; 2008 Feb; 388(1-2):84-8. PubMed ID: 17980158
[TBL] [Abstract][Full Text] [Related]
20. Role of Interleukin-10 (-1082A/G) gene polymorphism with the risk of ischemic stroke: a meta-analysis.
Kumar P; Yadav AK; Misra S; Kumar A; Chakravarty K; Prasad K
Neurol Res; 2016 Sep; 38(9):823-30. PubMed ID: 27363685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
